News center

SHARE ON

2022-09-09

Zero breakthrough! Guangzhou Pharmaceutical Group successfully obtained the first license for manufacturing oral solid preparations of traditional Chinese medicine (including liniment for external use) in Macao.

Guangzhou Pharmaceutical International (Macau) Qingzhou Pharmaceutical Factory, a subsidiary of Guangzhou Pharmaceutical Group, has obtained the license for manufacturing traditional Chinese medicine, which is the first license for manufacturing oral solid preparations of traditional Chinese medicine (including liniments for external use) in Macau issued by the Drug Administration of the Macao Special Administrative Region Government. It is worth mentioning that in the same type of license, the license obtained by Guangzhou Pharmaceutical International (Macau) Qingzhou Pharmaceutical Factory contains the most dosage forms of Chinese patent medicines.